Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000891804-05-000452
Filing Date
2005-02-09
Accepted
2005-02-09 13:21:56
Documents
1
Group Members
WAM ACQUISITION GP, INC.

Document Format Files

Seq Description Document Type Size
1 ENZON PHARMACEUTICALS, INC. enzon.txt SC 13G/A 13698
  Complete submission text file 0000891804-05-000452.txt   16271
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 05587746
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000